OpenAI acquires Orchestra Bio to expand AI-assisted drug discovery
markchen90 · x · 2026-10-21
OpenAI announced its acquisition of Orchestra Bio, a platform helping biopharma teams coordinate drug development, with leader Ashok Raj joining the company. The team will build on Rosalind and OpenAI's life sciences models to streamline drug development operations and speed new treatments to patients.
Related event: OpenAI Acquires Orchestra Bio to Push AI Agents into Drug Development(13 posts)→
More from Companies & People
- NJIT's top research honor goes to HPC pioneer David Bader — Prof_DavidBader · 2026-10-21
- Cloudflare's first Cold Start contest: Haelo Health wins $500k, Polylane takes $100k — threepointone · 2026-10-21
- Together AI hiring PhD research interns for summer 2027 on text and speech agents — coryshain · 2026-10-21
- Spotify removed 50M+ AI slop tracks from recommendations in a year to back human artists — moustaki · 2026-10-21
- Mistral CEO Arthur Mensch on European AI sovereignty, gigawatt-scale infra and AGI risk — beffjezos · 2026-10-21
- Sundar Pichai to appear on Alex Heath's Sources podcast tomorrow — gaganghotra_ · 2026-10-21